BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 28631652)

  • 1. Primary cutaneous large B-cell lymphoma of scalp: Case report of a rare variant.
    Khatib Y; Dande M; Patel RD; Makhija M
    Indian J Pathol Microbiol; 2017; 60(2):268-271. PubMed ID: 28631652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An atypical presentation of primary cutaneous diffuse B-cell lymphoma, leg type].
    Brouillard C; Granel-Brocard F; Montagne K; Bastien C; Barbaud A; Schmutz JL
    Ann Dermatol Venereol; 2011; 138(8-9):601-4. PubMed ID: 21893235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomorphology of a case of primary cutaneous B-cell lymphoma.
    Jain M; Agarwal K; Langer S; Aggarwal M
    Indian J Pathol Microbiol; 2007 Oct; 50(4):877-80. PubMed ID: 18306596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case of Transformation of Primary Cutaneous Follicle Center Lymphoma to Diffuse Large B-Cell Lymphoma Involving the Parotid Gland and Cervical Lymph Nodes.
    King ML; Vengaloor Thomas T; Albert AA; Joseph S; Ramachandran Nair L; Lam JT; Woods WC; Nittala M; Vijayakumar S
    Am J Case Rep; 2019 Aug; 20():1273-1278. PubMed ID: 31462626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scalp tumour as a sign of systemic B-cell lymphoma.
    Magina S; Mesquita-Guimarães J; Resende C; Bello M; Dias C
    J Eur Acad Dermatol Venereol; 2004 Mar; 18(2):196-8. PubMed ID: 15009304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous follicle center cell lymphoma.
    Cerroni L; Kerl H
    Leuk Lymphoma; 2001; 42(5):891-900. PubMed ID: 11697644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin's lymphoma.
    Colovic N; Jurisic V; Terzic T; Atkinson HD; Colovic M
    Arch Dermatol Res; 2009 Oct; 301(9):689-92. PubMed ID: 19495780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification.
    Suárez AL; Pulitzer M; Horwitz S; Moskowitz A; Querfeld C; Myskowski PL
    J Am Acad Dermatol; 2013 Sep; 69(3):329.e1-13; quiz 341-2. PubMed ID: 23957984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
    Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
    Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous B-cell lymphomas with large cell predominance-primary cutaneous follicle center lymphoma, diffuse large B-cell lymphoma, leg type and intravascular large B-cell lymphoma.
    Hope CB; Pincus LB
    Semin Diagn Pathol; 2017 Jan; 34(1):85-98. PubMed ID: 28065463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary cutaneous follicle centre lymphoma: report of a case].
    Rong YF; He LM; Zhang YS; Feng YZ
    Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):769-70. PubMed ID: 24447559
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary Cutaneous Follicle Center Lymphoma.
    Skala SL; Hristov B; Hristov AC
    Arch Pathol Lab Med; 2018 Nov; 142(11):1313-1321. PubMed ID: 30407851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse large B-cell lymphoma mimicking advanced basal cell carcinoma.
    Akinyemi E; Mai L; Matin A; Maini A
    J Natl Med Assoc; 2007 Aug; 99(8):948-50. PubMed ID: 17722675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete remission of a primary cutaneous follicle-center cell lymphoma (EORTC criteria)/diffuse large B-cell lymphoma (WHO criteria) by single first-line therapy with rituximab.
    Nagasaka A; Matsue H; Kawamura T; Kanzaki M; Inozume T; Nakamura Y; Shimzu A; Shibagaki N; Yanagi M; Shimada S
    J Dermatol; 2006 May; 33(5):377-9. PubMed ID: 16700675
    [No Abstract]   [Full Text] [Related]  

  • 15. [Relapse of diffuse large B cell lymphoma to CD20-negative multiple cutaneous tumors immediately after anti-CD20 monoclonal antibody (rituximab) therapy].
    Iguchi T; Miyazawa K; Okabe S; Kawakubo K; Shimamoto T; Kuriyama Y; Ito Y; Kimura Y; Ohyashiki K; Serizawa H; Iwaya K; Mukai K
    Rinsho Ketsueki; 2004 Oct; 45(10):1129-34. PubMed ID: 15553050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical clinical presentation of primary and secondary cutaneous follicle center lymphoma (FCL) on the head characterized by macular lesions.
    Massone C; Fink-Puches R; Cerroni L
    J Am Acad Dermatol; 2016 Nov; 75(5):1000-1006. PubMed ID: 27380773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous diffuse large B-cell lymphoma, leg type: diagnostic considerations.
    Hristov AC
    Arch Pathol Lab Med; 2012 Aug; 136(8):876-81. PubMed ID: 22849734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cutaneous large B-cell leg-type lymphoma occurring on a leg burn].
    Meziane M; Hesse S; Chetaille B; Bien-Aimée A; Grob JJ; Richard MA
    Ann Dermatol Venereol; 2009 Nov; 136(11):791-4. PubMed ID: 19917431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-Cell-Rich Recurrence of Primary Cutaneous Follicle Center Lymphoma After Systemic Rituximab: A Diagnostic Pitfall.
    Santonja C; Prieto-Torres L; Pérez-Sáenz MLÁ; Requena L; Rodríguez-Pinilla SM
    Am J Dermatopathol; 2020 Mar; 42(3):e36-e40. PubMed ID: 31592859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic features of early lesions of primary cutaneous follicle center lymphoma, diffuse type: implications for early diagnosis and treatment.
    Gulia A; Saggini A; Wiesner T; Fink-Puches R; Argenyi Z; Ferrara G; Müller CS; Vale E; Cerroni L
    J Am Acad Dermatol; 2011 Nov; 65(5):991-1000. PubMed ID: 21704419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.